Immediate release fixed dose combination product [Regulatives / Guidelines]

posted by ping4santosh  – India, 2020-03-11 15:22 (1111 d 06:47 ago) – Posting: # 21245
Views: 3,981

Dear Dr Dan,

Please accept my apology for spelling your name wrongly in my last draft.

Please allow me to ask you why you consider this as a new product? Both the APIs are registered as individual products in market and we are just combining both. Why would you call it as a new product that needs Efficacy and Safety data?

Thank you,
SKM

Complete thread:

UA Flag
Activity
 Admin contact
22,553 posts in 4,724 threads, 1,606 registered users;
17 visitors (0 registered, 17 guests [including 10 identified bots]).
Forum time: 23:10 CEST (Europe/Vienna)

Learning of many things
does not teach intelligence.    Heraclitus of Ephesus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5